Quality of Life Study

Thank you for visiting this page. Whether you are a patient or one of our referral partners, we appreciate your interest and support.

As part of our passionate mission to support our patients in their desire to live life well, we are committed to research concerning the conditions our therapies treat. With this in mind, Dr. Robert Singh, Medical Director of our PA/NJ clinics and Clinical Trials Services, spearheads Vivo Infusion’s participation in the Multiple Sclerosis Quality of Life [MS-QOL-54) STUDY. 

The MSQOL-54 is a structured, self-report questionnaire that the patient can generally complete with little or no assistance. Some patients, such as those with visual or upper extremity impairments, may need to have the MSQOL-54 administered as an interview. In such cases, Vivo will provide an interviewer who is trained in basic interviewing skills and the use of this instrument.

Currently, our participating locations are Bethlehem, Broomall, Center City, Jenkintown and Royersford in Pennsylvania as well as  Cherry Hill and Princeton in New Jersey.

We cannot do this without the support of our amazing MS Warriors. If you are willing and able to help us with this impactful study, please complete the Patient Consent form below and submit it to your Vivo Infusion treatment clinic. Alternatively, you can click on the CONTACT ME button at the bottom of this page to request a member of our study team contact you.

Introduction

Patient Brochure

General FAQ

Patient Letter

Patient Consent

Questions About the Study

For specific questions about this study, please contact our Director of Clinical Trial Services, Dr. Robert Singh, by phone at (610) 427-3841 or by email at research@vivoinfusion.com.

For compliance concerns, please email Francine Wachtmann, Chief Compliance Officer, at fwachtmann@vivoinfusion.com.